Výsledky vyhledávání

Cessation versus continuation of 6-month migraine preventive therapy with topiramate (PROMPT): a randomised, double-blind, placebo-controlled trial

Autor: Diener, H, Agosti, R, Allais, G, Bergmans, P, Bussone, G, Davies, B, Ertas, M, Lanteri Minet, M, Reuter, U, Del Río, MS, Schoenen, J, Schwalen, S, van Oene, J, TOPMAT MIG 303 Investigators Group, C. Lampl, T. Berger, J. Jacquy, L. Herroelen, P. Louis, J. Schoenen, I. Milanov, Z. Zahariev, S. Bozhinov, P. Dočekal, M. Grünermelová, G. Waberžinek, P. Tfelt Hansen, M. Groenbech Jensen, I. Tsiropoulos, R. Kirkeby, M. J. Rasmussen, D. Valade, H. Massiou, C. Sereni, A. Donnet, M. Lanteri Minet, C. Lucas, G. Mick, A. Pradalier, E. Guegan Massardier, H. C. Diener, S. Evers, U. Reuter, A. Straube, D. Mitsikostas, K. Karageorgiou, I. Milonas, G. Georgiadis, G. Gyula, Á. Judit, H. Péter, V. László, O. Hardiman, B. Sweeny, L. Grazzi, B. Colombo, G. Bruzzone, A. Quattrone, C. Benedetto, G. D'Andrea, P. Barbanti, R. De Simone, F. Valguarnera, M. A. Al Jumah, A. Al Tahan, I. Monstad, R. sj, R. Salvesen, LJ Stovner, H. Kwiecinski, W. Fryze, D. Pruchnik Wolinska, R. Motyl, W. Kozubsk, K. Ulatowska Blaszyk, A. Prusinski, L. Cunha, J. Pereira Monteiro, P. Esperança, A. Boyko, A. Skoromets, T. Pogačnik, T. Hojs Fabjan, M. Sánchez Del Río, R. Agosti, F. Donati, B. Tettenborn, M. Siccoli, A. Siva, M. Ertaş, M. Zarifoğlu, B. Davies, P. Davies, D. Bates, M. Fontebasso, P. Cleland, S. Lipscombe, A. Dowson, M. Lawden, S. McPhee, B. Calder, FERRARESE, CARLO

Publikováno v: The Lancet Neurology. 6:1054-1062

BACKGROUND: Use of preventive therapy for migraine is often recommended for only 6-9 months, but no randomised, placebo-controlled trials have investigated migraine frequency after the end of prophylaxis. We assessed the effects of discontinuation of

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b22841f260663d94791b83518d646dfe
https://doi.org/10.1016/s1474-4422(07)70272-7

Zobrazit plný text záznamu

[Cerebral apoplexy--anticardiolipin antibody and factor V Leiden mutation]

Autor: R, Kirkeby, O D, Pedersen

Publikováno v: Ugeskrift for laeger. 159(15)

A case of a twenty-nine year old woman with ischaemic stroke documented by Magnetic Resonance Imaging scanning is reported. As no embolic source was identified, it was most likely that the ischaemic stroke was caused by in situ arterial thrombosis. E

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::34eb8c24c16f2ed8ddd54ae98bcef3f9
https://pubmed.ncbi.nlm.nih.gov/9148550

Zobrazit plný text záznamu

[Treatment of spasticity with a transcutaneous neurostimulator. A pilot study]

Autor: R, Kirkeby, M, Jordt, E, Hansen

Publikováno v: Ugeskrift for laeger. 157(17)

In this pilot study the neurostimulator KDC 5000 is used with efficacy on seven out of 11 patients with spastic palsy, and treatment was given without any side-effects. No other treatment has sufficiently helped these patients, and we therefore concl

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::e79fb6b2b75d576c98061233060aba07
https://pubmed.ncbi.nlm.nih.gov/7762102

Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání